H.R. 1222House115th Congress (2017-2019)Enacted

Congenital Heart Futures Reauthorization Act of 2017

Introduced February 27, 2017

AI-Generated Summary

Updated April 15, 2026 at 1:23 PM UTC

The Congenital Heart Futures Reauthorization Act of 2017 updates the Public Health Service Act to strengthen federal efforts on congenital heart disease. It directs the HHS Secretary to expand research, data collection, and public‑education activities, and to fund these programs with $10 million each year from FY 2020 through FY 2024. The law also requires a three‑year progress report to Congress.

Key Provisions

  • Mandates the Secretary of HHS to enhance research and nationwide data collection on congenital heart disease, including a national cohort study and population‑based surveillance.
  • Requires public‑awareness and education campaigns aimed at patients, families, and health‑care providers about the disease’s prevalence, impact, and need for specialized care.
  • Authorizes grants of up to $10 million annually (FY 2020‑2024) to public or private nonprofit entities with expertise in congenital heart disease, subject to an application process.
  • Ensures that collected data are made publicly available for researchers while protecting patient privacy under federal and state law.
  • Calls for a comprehensive report to Congress within three years of enactment summarizing activities, research findings, gaps, and future needs.

Legislative Activity

Stay on top of the latest movement without scrolling through every action

33 earlier actions
Became Law Latest Action

Became Public Law No: 115-342.

December 21, 2018

View full timeline
HouseIntro Referral

Introduced in House

February 27, 2017

HouseIntro Referral

Referred to the House Committee on Energy and Commerce.

February 27, 2017

HouseCommittee

Referred to the Subcommittee on Health.

March 3, 2017

HouseCommittee

Subcommittee Consideration and Mark-up Session Held.

May 18, 2017

HouseCommittee

Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .

May 18, 2017

HouseCommittee

Committee Consideration and Mark-up Session Held.

June 7, 2017

HouseCommittee

Ordered to be Reported (Amended) by Voice Vote.

June 7, 2017

HouseCommittee

Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 115-329.

September 25, 2017

HouseCalendars

Placed on the Union Calendar, Calendar No. 239.

September 25, 2017

HouseFloor

Mr. Burgess moved to suspend the rules and pass the bill, as amended.

February 26, 2018 • 5:21 PM

HouseFloor

Considered under suspension of the rules. (consideration: CR H1238-1240)

February 26, 2018 • 5:21 PM

HouseFloor

DEBATE - The House proceeded with forty minutes of debate on H.R. 1222.

February 26, 2018 • 5:21 PM

HouseFloor

At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.

February 26, 2018 • 5:35 PM

HouseFloor

Considered as unfinished business. (consideration: CR H1246-1247)

February 26, 2018 • 6:31 PM

HouseFloor

Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 394 - 7 (Roll no. 81).(text: CR H1238-1239)

February 26, 2018 • 6:56 PM

HouseFloor

On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 394 - 7 (Roll no. 81). (text: CR H1238-1239)

February 26, 2018 • 6:56 PM

HouseFloor

Motion to reconsider laid on the table Agreed to without objection.

February 26, 2018 • 6:56 PM

SenateIntro Referral

Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

February 27, 2018

SenateCommittee

Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.

July 25, 2018

SenateCommittee

Committee on Health, Education, Labor, and Pensions. Reported by Senator Alexander with an amendment in the nature of a substitute. Without written report.

August 15, 2018

SenateCalendars

Placed on Senate Legislative Calendar under General Orders. Calendar No. 555.

August 15, 2018

SenateFloor

Measure laid before Senate by unanimous consent. (consideration: CR S7524-7525)

December 12, 2018

SenateFloor

The committee substitute withdrawn by Unanimous Consent. (CR S7525)

December 12, 2018

SenateFloor

Passed Senate with an amendment by Unanimous Consent.

December 12, 2018

SenateFloor

Message on Senate action sent to the House.

December 13, 2018

HouseResolving Differences

Mr. Walden moved that the House suspend the rules and agree to the Senate amendment. (consideration: CR H10278-10280, H10313-10314)

December 19, 2018 • 3:03 PM

HouseFloor

DEBATE - The House proceeded with forty minutes of debate on the Senate amendment to H.R. 1222.

December 19, 2018 • 3:03 PM

HouseResolving Differences

At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the chair announced that further proceedings on the motion would be postponed.

December 19, 2018 • 3:19 PM

HouseNot Used

Resolving differences -- House actions: On motion that the House suspend the rules and agree to the Senate amendment Agreed to by the Yeas and Nays: (2/3 required): 355 - 7 (Roll no. 436).(text: CR H10278)

December 19, 2018

HouseResolving Differences

On motion that the House suspend the rules and agree to the Senate amendment Agreed to by the Yeas and Nays: (2/3 required): 355 - 7 (Roll no. 436). (text: CR H10278)

December 19, 2018 • 6:58 PM

HouseResolving Differences

Motion to reconsider laid on the table Agreed to without objection.

December 19, 2018 • 6:58 PM

President

Presented to President.

December 21, 2018

Became Law

Signed by President.

December 21, 2018

Became Law

Became Public Law No: 115-342.

December 21, 2018

Amendments

1 amendment

Offered to this bill

Floor Debate

12 members

What members said about H.R. 1222 on the floor

9 Republicans3 Democrats
Greg Walden
Rep. Greg WaldenR-OR-2 · Dec 19, 2018

Mr. Speaker, I move to suspend the rules and concur in the Senate amendment to the bill (H.R. 1222) to amend the Public Health Service Act to coordinate Federal congenital heart disease research…

Gus M. Bilirakis
Rep. Gus M. BilirakisR-FL-12 · Dec 19, 2018

Mr. Speaker, I thank the chairman for yielding me time. I appreciate all his help on this particular bill, and the committee's help as well. It has been a priority of ours. Mr. Speaker, I rise today…

Gus M. Bilirakis
Rep. Gus M. BilirakisR-FL-12 · Feb 26, 2018

Mr. Speaker, I rise today in support of H.R. 1222, the Congenital Heart Futures Reauthorization Act, which will reauthorize and ensure continued investment in surveillance research to assess the…

Bill Huizenga
Rep. Bill HuizengaR-MI-2 · Mar 6, 2018

Mr. Speaker, I rise today regarding missed votes due to a mild medical issue. Had I been present for roll call vote number 81, on Motion to Suspend the Rules and Pass, as Amended, H.R. 1222 the…

Billy Long
Rep. Billy LongR-MO-7 · Mar 6, 2018

Mr. Speaker, on Monday, February 26, 2018, and Tuesday, February 27, 2018 I was unable to vote on any legislative measures. Had I been present, I would have voted the following: (Roll no. 81) On…

Show 8 more
Michael C. Burgess
Rep. Michael C. BurgessR-TX-26 · Dec 19, 2018

Mr. Speaker, I thank the chairman for yielding me time this afternoon. Supporting H.R. 1222 is important. This is the Congenital Heart Futures Reauthorization Act. This important piece of legislation…

Gene Green
Rep. Gene GreenD-TX-29 · Feb 26, 2018

Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, I rise in support of H.R. 1222, the Congenital Heart Futures Reauthorization Act, led by Congressman Bilirakis and Congressman…

Mac Thornberry
Rep. Mac ThornberryR-TX-13 · Dec 20, 2018

Mr. Speaker, on Wednesday, December 19, 2018, I was unable to be in Washington and missed roll call votes No. 436 ``Concurring in the Senate Amendment to H.R. 1222--Congenital Heart Futures…

Michael C. Burgess
Rep. Michael C. BurgessR-TX-26 · Feb 26, 2018

Mr. Speaker, I move to suspend the rules and pass the bill (H.R. 1222) to amend the Public Health Service Act to coordinate Federal congenital heart disease research efforts and to improve public…

Paul Tonko
Rep. Paul TonkoD-NY-20 · Dec 19, 2018

Mr. Speaker, I yield myself as much time as I may consume. Mr. Speaker, I rise in support of the Senate amendment to H.R. 1222, the Congenital Heart Futures Reauthorization Act led by Congressman…

Earl L. "Buddy" Carter
Rep. Earl L. "Buddy" CarterR-GA-1 · Feb 26, 2018

Mr. Speaker, I thank the gentleman for yielding. Mr. Speaker, I rise today in support of the Congenital Heart Futures Reauthorization Act. This legislation was introduced by the gentleman from…

Adam Smith
Rep. Adam SmithD-WA-9 · Mar 1, 2018

Mr. Speaker, on Monday, February 26 and Tuesday, February 27, 2018, I was not present for recorded votes. I would have voted: ``YES'' on roll call vote No. 81 (on the motion to suspend the rules and…

Cory Gardner
Sen. Cory GardnerR-CO · Dec 12, 2018

Mr. President, I ask unanimous consent that the Senate proceed to the immediate consideration of Calendar No. 555, H.R. 1222. I ask unanimous consent that the committee-reported substitute amendment…

Show 1 more
Thomas Massie
Rep. Thomas MassieR-KY-4 · Dec 19, 2018

Mr. Speaker, on that I demand the yeas and nays.

Bill Text

8 versions available

Reading Mode
Latest
Enrolled BillPublication date not provided

One Hundred Fifteenth Congress of the United States of America

At the Second Session

Begun and held at the City of Washington on Wednesday, the third day of January, two thousand and eighteen

H. R. 1222

AN ACT

To amend the Public Health Service Act to coordinate Federal congenital heart disease research efforts and to improve public education and awareness of congenital heart disease, and for other purposes.

1.

Short title

This Act may be cited as the Congenital Heart Futures Reauthorization Act of 2017.

2.

National congenital heart disease research, surveillance, and awareness

Section 399V–2 of the Public Health Service Act (42 U.S.C. 280g–13) is amended to read as follows:

399V–2.

National congenital heart disease research, surveillance, and awareness

(a)

In general

The Secretary shall, as appropriate—

(1)

enhance and expand research and data collection efforts related to congenital heart disease, including to study and track the epidemiology of congenital heart disease to understand health outcomes for individuals with congenital heart disease across all ages;

(2)

conduct activities to improve public awareness of, and education related to, congenital heart disease, including care of individuals with such disease; and

(3)

award grants to entities to undertake the activities described in this section.

(b)

Activities

(1)

In general

The Secretary shall carry out activities, including, as appropriate, through a national cohort study and a nationally-representative, population-based surveillance system, to improve the understanding of the epidemiology of congenital heart disease in all age groups, with particular attention to—

(A)

the incidence and prevalence of congenital heart disease in the United States;

(B)

causation and risk factors associated with, and natural history of, congenital heart disease;

(C)

health care utilization by individuals with congenital heart disease;

(D)

demographic factors associated with congenital heart disease, such as age, race, ethnicity, sex, and family history of individuals who are diagnosed with the disease; and

(E)

evidence-based practices related to care and treatment for individuals with congenital heart disease.

(2)

Permissible considerations

In carrying out the activities under this section, the Secretary may, as appropriate—

(A)

collect data on the health outcomes, including behavioral and mental health outcomes, of a diverse population of individuals of all ages with congenital heart disease, such that analysis of the outcomes will inform evidence-based practices for individuals with congenital heart disease; and

(B)

consider health disparities among individuals with congenital heart disease, which may include the consideration of prenatal exposures.

(c)

Awareness campaign

The Secretary may carry out awareness and educational activities related to congenital heart disease in individuals of all ages, which may include information for patients, family members, and health care providers, on topics such as the prevalence of such disease, the effect of such disease on individuals of all ages, and the importance of long-term, specialized care for individuals with such disease.

(d)

Public access

The Secretary shall ensure that, subject to subsection (e), information collected under this section is made available, as appropriate, to the public, including researchers.

(e)

Patient privacy

The Secretary shall ensure that the data and information collected under this section are made available in a manner that, at a minimum, protects personal privacy to the extent required by applicable Federal and State law.

(f)

Eligibility for grants

To be eligible to receive a grant under subsection (a)(3), an entity shall—

(1)

be a public or private nonprofit entity with specialized experience in congenital heart disease; and

(2)

submit to the Secretary an application at such time, in such manner, and containing such information as the Secretary may require.

(g)

Authorization of appropriations

To carry out this section, there are authorized to be appropriated $10,000,000 for each of fiscal years 2020 through 2024.

.

3.

Report

Not later than 3 years after the date of enactment of the Congenital Heart Futures Reauthorization Act of 2017, the Secretary of Health and Human Services shall submit to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives a report summarizing any activities carried out pursuant to section 399V–2 of the Public Health Service Act (as amended by section 2), including planned activities, and a summary of any research findings and ongoing research efforts, gaps, and areas of greatest need within the Department of Health and Human Services regarding congenital heart disease in patients of all ages.

Speaker of the House of Representatives.

Vice President of the United States and President of the Senate.